Northpond Ventures, LP 13D and 13G filings for Candel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:32 pm Sale | 2024-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 0 0.000% | -1,935,215 (Position Closed) | Filing |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | Candel Therapeutics, Inc. CADL | Northpond Ventures, LP | 1,935,215 6.700% | 1,935,215 (New Position) | Filing |